Focus Taiwan App
Download

Confusion around failure of deal to import possible COVID-19 vaccine

11/03/2020 10:30 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Nov. 3 (CNA) A Taiwanese biotechnology company that said last month it had been authorized by a German company to sell a prospective COVID-19 vaccine announced on Tuesday that it had failed to negotiate a distribution agreement with Taiwan's government, but the two sides offered conflicting explanations as to the reasons why.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.236